Protective Role of Tuftsin Fragment 1-3 in an Animal Model of Intracerebral Hemorrhage

Annals of Neurology

Volumn 54, Issue 5, 2003, Pages 655-664

  Wang, Jian ^d   Rogove, Andrew D ^a   Tsirka, Anna E ^b   Tsirka, Stella E ^c  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; MACROPHAGE MIGRATION INHIBITION FACTOR; TISSUE PLASMINOGEN ACTIVATOR; TUFTSIN; TUFTSIN FRAGMENT 1-3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; MICROGLIA; MOUSE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STROKE;

ANIMALS; BRAIN; CEREBRAL HEMORRHAGE; COLLAGENASES; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; INJECTIONS, INTRAVENTRICULAR; MATRIX METALLOPROTEINASES; MICE; MICROGLIA; TISSUE PLASMINOGEN ACTIVATOR; TUFTSIN;

EID: 0242384661     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10750     Document Type: Article

References (24)

1. Qureshi AI, Tuhrim S, Broderick JP, et al. Spontaneous intracerebral hemorrhage. N Engl J Med 2001;344:1450-1460.
2. Matsushita K, Meng W, Wang X, et al. Evidence for apoptosis after intracerebral hemorrhage in rat striatum. J Cereb Blood Flow Metab 2000;20:396-404.
3. Gong C, Boulis N, Qian J, et al. Intracerebral hemorrhage-induced neuronal death. Neurosurgery 2001;48:875-882; discussion, 882-883.
4. Hickenbottom SL, Grotta JC, Strong R, et al. Nuclear factor-kappa B and cell death after experimental intracerebral hemorrhage in rats. Stroke 1999;30:2472-2477; discussion, 2477-2478.
5. Gong C, Hoff JT, Keep RF. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Res 2000;871:57-65.
6. Castillo J, Davalos A, Alvarez-Sabin J, et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 2002;58:624-629.
7. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991;88:1067-1072.
8. Meschia JF, Miller DA, Brott TG. Thrombolytic treatment of acute ischemic stroke. Mayo Clin Proc 2002;77:542-551.
9. Zivin JA. Thrombolytic stroke therapy: past, present, and future. Neurology 1999;53:14-19.
10. Wang YF, Tsirka SE, Strickland S, et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 1998;4:228-231.
11. Rogove AD, Siao C, Keyt B, et al. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci 1999;112:4007-4016.
12. Tsirka SE, Rogove AD, Bugge TH, et al. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 1997;17:543-552.
13. Thanos S, Mey J, Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J Neurosci 1993;13:455-466.
14. Auriault C, Joseph M, Tartar A, Capron A. Characterization and synthesis of a macrophage inhibitory peptide from the second constant domain of human immunoglobulin G. FEBS Lett 1983;153:11-15.
15. Clark W, Gunion-Rinker L, Lessov N, Hazel K. Citicole treatment for experimental intracerebral hemorrhage in mice. Stroke 1998;29:2136-2140.
16. Carmeliet P, Schoonjans L, Kieckens L, et al. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994;368:419-424.
17. Schmued LC, Hopkins KJ. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000;874:123-130.
18. Clark WM, Lessov NS, Dixon MP, Eckenstein F. Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol Res 1997;19:641-648.
19. Rogove AD, Tsirka SE. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 1998;8:19-25.
20. Choudhri T, Hoh B, Solomon R, et al. Use of spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke 1997;28:2296-2302.
21. Peeling J, Yan H-J, Corbett D, et al. Effect of FK-506 on inflammation and behavioral outcome following intracerebral hemorrhage in rat. Exp Neurol 2001;167:341-347.
22. Rohde V, Rohde I, Thiex R, et al. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage:rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg 2002;97:954-962.
23. Overgaard K, Sperling B, Boysen G, et al. Thrombolytic therapy in acute ischemic stroke. A Danish pilot study. Stroke 1993;24:1439-1446.
24. Liberatore G, Samson A, Bladin C, et al. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration. Stroke 2003;34:537-543.